Commentary

PCC
Gandhian Concepts on Mental Health in Contemporary COVID-19 Pandemic Times
Commentary

April 19, 2022

In this commentary, the authors discuss Gandhi’s views on mental health, especially in the context of the COVID-19 pandemic.
, , , et al
PCC
US Suicide Rates and Impact of Major Disasters
Commentary

April 12, 2022

This commentary explores the impact of major disasters on suicide rates, especially in the context of the COVID-19 pandemic.
, , , et al
JCP
What Is the Role of Digital Medicine for Adherence Monitoring in Patients With SMI?
Commentary

April 11, 2022

This commentary looks at the benefits and limitations of digital medicine systems and discusses a recent trial in schizophrenia patients by Cohen et al.
JCP
Functional Outcomes of an Antipsychotic in Schizophrenia: Generalizable or Specific Effect?
Commentary

March 1, 2022

This commentary takes a closer look at Correll and colleagues’ findings on functional outcomes with brexpiprazole.
PCC
Commentary

January 20, 2022

In this commentary, the authors discuss biological similarities of the opioid epidemic and the COVID-19 pandemic, as well as differences in response to the 2 public health crises.
, ,
PCC
Commentary

January 20, 2022

Patients with psychiatric disorders may be at greater risk of experiencing adverse outcomes from COVID-19. Read on to find out more.
, ,
JCP
Commentary

January 18, 2022

This commentary discusses the article by Zeifman and colleagues on the role classic psychedelic agents may have in reducing risk of suicide.
,
JCP
Commentary

January 4, 2022

This commentary discusses the review by Vaccarino and colleagues of cognitive effects associated with ketamine treatment for major depressive disorder.
PCC
Commentary

December 16, 2021

In this commentary, the authors discuss the new Omicron variant of COVID-19 as well as the potential mental health challenges that will likely unfold over the next year.
,
PCC
Commentary

November 18, 2021

There are signs that the COVID-19 pandemic may disproportionately impact suicide rates among Black and other vulnerable populations in the US. This commentary explores this possibility in the context...
, ,
JCP
Commentary

November 9, 2021

In this commentary on an article by Amani and colleagues, Dr O’Hara discusses the role—and possible limits—of peer support for women with perinatal depression.
JCP
Commentary

November 2, 2021

This commentary discusses therapeutic inertia--failure to (1) establish an optimal treatment dose to reach a desired outcome and (2) change treatment when a first treatment does not produce remission—in...
PCC
Commentary

October 7, 2021

The issues related to the COVID-19 pandemic pose a unique challenge for those with autism spectrum disorder and their caregivers as well. Read this commentary to find out more.
, ,
PCC
Commentary

September 23, 2021

In this commentary, the author discusses the mental health effects of the second wave of the COVID-19 tsunami in India.
JCP
Commentary

August 3, 2021

This commentary discusses the results of a recent JCP article on the National Pregnancy Registry for Atypical Antipsychotics.
,
JCP
Commentary

May 18, 2021

This commentary discusses the article by Dubreucq and colleagues that examined objective and subjective aspects of recovery among clinically stable outpatients with schizophrenia spectrum disorders.
,
PCC
Commentary

May 6, 2021

In this commentary, the authors discuss the challenges in Iraq with regard to mental health care, especially in the context of COVID-19.
, , , et al
PCC
Commentary

April 29, 2021

Could increased social cohesion through shared experience mitigate the impact of pandemics on suicide rates? Here, the authors explore the impact of the 1918–1920 influenza pandemic on suicide rates...
, , , et al
JCP
Commentary

March 30, 2021

This commentary discusses a recent article on the use of electroconvulsive therapy for depressed patients with and without borderline personality disorder.
PCC
Commentary

March 18, 2021

In this commentary, the authors discuss the impact of COVID-19 on patients with schizophrenia and their access to care.
, , , et al
PCC
Commentary

March 18, 2021

In this commentary, the authors discuss coronaphobia and the advancements that have been made to understand, measure, and treat this reaction to stress related to COVID-19.
,
PCC
Commentary

February 18, 2021

In this commentary, the author describes factors associated with suicide among doctors during the COVID-19 pandemic and provides possible interventions.
PCC
Commentary

January 21, 2021

In this commentary, the authors discuss the challenges with regard to treating patients with multiple sclerosis during the COVID-19 pandemic.
, , , et al
JCP
Commentary

January 19, 2021

This commentary discusses a recent brief report by Pietrzak et al and lists 3 strategies that health care systems could use to improve mental health support for frontline health...
,

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe